You are here

Small Peripheral Vessel Graft

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43HL149418-01
Agency Tracking Number: R43HL149418
Amount: $325,534.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NHLBI
Solicitation Number: PA18-574
Timeline
Solicitation Year: 2018
Award Year: 2019
Award Start Date (Proposal Award Date): 2019-09-01
Award End Date (Contract End Date): 2020-05-31
Small Business Information
11107 ROSELLE ST, STE 213
San Diego, CA 92121-1206
United States
DUNS: 804419740
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 TERRY HUBBARD
 (858) 249-7409
 thubbard@3dtholdings.com
Business Contact
 GHASSAN KASSAB
Phone: (858) 249-7400
Email: gkassab@3dtholdings.com
Research Institution
N/A
Abstract

ABSTRACT Peripheral arterial disease may lead to critical limb ischemia and results in amputation of the limb in severe manifestationsThe prevalence rate of peripheral arterial disease increases fromin those younger thanyears toin thoseyears or olderIn the United Statesovermillion individuals have lower extremity PADwith combined annual costs exceeding $billionSurgical bypass of the diseased peripheral arterial segment is one of the main treatments for the patients with life limiting claudication or critical limb ischemiaAutogenous vein graft is the most commonly used conduit in the bypass surgeryUnfortunatelythere are a limited number of bypasses that can be made from autogenous vein graftsCurrent alternative approaches include synthetic materialacellular scaffoldsand tissue engineered graftsbut all have failed to produce a functional small diameter graftThusthere is a critical need for readily available grafts for bypass surgeryIn this proposalwe will evaluate the pulmonary visceral pleuraPVPas a novel biological scaffold for bypass surgery in peripheral arterial diseaseOur group has preliminary data showing small diametermmglutaraldehyde fixed PVP grafts remain patent atmonths in a rat model where the graft fully and functionally arterializes and with no indications of calcification or aneurysmIn this proposalwe aim to expand upon our preliminary findings and evaluate the safety and efficacy of PVP as small diametermmgrafts for peripheral artery surgery in a swine modelThis proposal addresses a clinically very significant problem and successful completion will provide surgeons with numerous conduit size optionsto minimize SV harvestingand reduce procedure time and healthcare costs NARRATIVE Surgical bypass of obstructive artery is one of the most widely performed operations in peripheral arterial disease but is limited by a critical need for readily available small diameter vessel graftsThe purpose of this Phase I SBIR is to test and validate the pulmonary visceral pleura as a small diameter vessel graft for bypass surgery

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government